Schoch P - Search Results

1

Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor.

Rothstein JD, Guidotti A, Tinuper P, Cortelli P, Avoni P, Plazzi G, Lugaresi E, Schoch P, Montagna P. Rothstein JD, et al. Among authors: schoch p. Lancet. 1992 Oct 24;340(8826):1002-4. doi: 10.1016/0140-6736(92)93011-b. Lancet. 1992. PMID: 1357403 Free article.

2

Idiopathic recurring stupor: a case with possible involvement of the gamma-aminobutyric acid (GABA)ergic system.

Tinuper P, Montagna P, Cortelli P, Avoni P, Lugaresi A, Schoch P, Bonetti EP, Gallassi R, Sforza E, Lugaresi E. Tinuper P, et al. Among authors: schoch p. Ann Neurol. 1992 May;31(5):503-6. doi: 10.1002/ana.410310507. Ann Neurol. 1992. PMID: 1317696

3

Idiopathic recurring stupor.

Tinuper P, Montagna P, Plazzi G, Avoni P, Cerullo A, Cortelli P, Sforza E, Bonetti EP, Schoch P, Rothstein JD, et al. Tinuper P, et al. Among authors: schoch p. Neurology. 1994 Apr;44(4):621-5. doi: 10.1212/wnl.44.4.621. Neurology. 1994. PMID: 8164814

4

Plasma endogenous benzodiazepine-like activity in sleep disorders with excessive daytime sleepiness.

Montagna P, Sforza E, Tinuper P, Provini F, Plazzi G, Cortelli P, Schoch P, Rothstein JD, Lugaresi E. Montagna P, et al. Among authors: schoch p. Neurology. 1995 Sep;45(9):1783. doi: 10.1212/wnl.45.9.1783. Neurology. 1995. PMID: 7675250 No abstract available.

5

Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.

Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE. Facklam M, et al. Among authors: schoch p. J Pharmacol Exp Ther. 1992 Jun;261(3):1113-21. J Pharmacol Exp Ther. 1992. PMID: 1318371

6

The multiplicity of actions of benzodiazepine receptor ligands.

Haefely WE, Martin JR, Richards JG, Schoch P. Haefely WE, et al. Among authors: schoch p. Can J Psychiatry. 1993 Nov;38 Suppl 4:S102-8. Can J Psychiatry. 1993. PMID: 8306240 Review.

7

Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.

Facklam M, Schoch P, Haefely WE. Facklam M, et al. Among authors: schoch p. J Pharmacol Exp Ther. 1992 Jun;261(3):1106-12. J Pharmacol Exp Ther. 1992. PMID: 1318370

8

Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.

Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, Richards JG. Haefely W, et al. Among authors: schoch p. Adv Biochem Psychopharmacol. 1992;47:379-94. Adv Biochem Psychopharmacol. 1992. PMID: 1324584 Review.

9

Novel anxiolytics that act as partial agonists at benzodiazepine receptors.

Haefely W, Martin JR, Schoch P. Haefely W, et al. Among authors: schoch p. Trends Pharmacol Sci. 1990 Nov;11(11):452-6. doi: 10.1016/0165-6147(90)90126-s. Trends Pharmacol Sci. 1990. PMID: 1980040 Review.

10

Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.

Moreau JL, Jenck F, Pieri L, Schoch P, Martin JR, Haefely WE. Moreau JL, et al. Among authors: schoch p. Eur J Pharmacol. 1990 Nov 6;190(1-2):269-73. doi: 10.1016/0014-2999(90)94138-n. Eur J Pharmacol. 1990. PMID: 1981753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters